Exercise and Colon Cancer
Status: | Active, not recruiting |
---|---|
Conditions: | Colorectal Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/10/2019 |
Start Date: | December 2015 |
The COURAGE Trial: Colon Recurrence and Aerobic Exercise: A Feasibility Study
Despite the success of surgery and chemotherapy among people with colon cancer, 30-50% of
patients develop recurrent disease. Physical activity has emerged as a potential lifestyle
intervention to reduce cancer recurrence and improve survival among people with colon cancer
(CC). This pilot study aims to identify the dose-response effects of aerobic exercise on
molecular and cellular pathways associated with physical activity and CC outcomes among
patients with stage II and III CC.
patients develop recurrent disease. Physical activity has emerged as a potential lifestyle
intervention to reduce cancer recurrence and improve survival among people with colon cancer
(CC). This pilot study aims to identify the dose-response effects of aerobic exercise on
molecular and cellular pathways associated with physical activity and CC outcomes among
patients with stage II and III CC.
Inclusion Criteria:
1. histologically confirmed TNM stage II-III CC;
2. completed surgical resection and adjuvant chemotherapy (if applicable) within 1-24
months before entering the study;
3. ≤120 min/wk of self-reported moderate or vigorous intensity physical activity using
the Paffenbarger physical activity questionnaire;
4. age ≥18 years;
5. written physician approval;
6. no additional surgery planned within the 6-month intervention (including colostomy
reversal);
7. ability to walk unaided for 6-minutes;
8. no contraindications to exercise using the PA readiness questionnaire (PAR-Q), unless
physician approves participation with specific knowledge of this contraindication.
Exclusion Criteria:
1. history of another primary invasive cancer (other than non-melanoma skin-cancer);
2. evidence of metastatic CC (i.e., TNM M1);
3. planning to receive any additional adjuvant chemotherapy;
4. pregnant or breast feeding;
5. unable to provide baseline blood sample;
6. cardiac conditions, including the following:
1. myocardial infarction or coronary revascularization procedure within prior 3
months;
2. uncontrolled hypertension (systolic ≥180 mmHg or diastolic ≥100 mmHg);
3. high-risk or uncontrolled arrhythmias;
4. clinically significant valvular disease;
5. decompensated heart failure;
6. known aortic aneurysm;
7. any other condition that may impede testing of the study hypothesis or make it unsafe
to engage in the exercise program (determined by the investigative team).
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials